Characteristics of study participants
. | Siblings, no. (%) . | Type of transplant . | . | . | . | |||
|---|---|---|---|---|---|---|---|---|
| Characteristics . | . | Any, no. (%) . | Autologous, no. (%) . | Related donor, no. (%) . | Unrelated donor, no. (%) . | |||
| No. | 317 (100.0) | 248 (100.0) | 28 (100.0) | 150 (100.0) | 70 (100.0) | |||
| Sex | ||||||||
| Male | 116 (36.6) | 137 (55.2) | 17 (60.7) | 89 (59.3) | 31 (44.3) | |||
| Female | 201 (63.4) | 111 (44.8) | 11 (39.3) | 61 (40.7) | 39 (55.7) | |||
| Race/ethnicity | ||||||||
| White | 294 (92.7) | 202 (81.4) | 26 (92.9) | 115 (76.7) | 61 (87.1) | |||
| Hispanic | 11 (0.3) | 25 (10.1) | 0 (0.0) | 21 (14.0) | 4 (5.7) | |||
| Other | 12 (0.4) | 21 (8.5) | 2 (7.1) | 14 (9.3) | 5 (7.2) | |||
| Age at interview | ||||||||
| Younger than 45 y | 166 (47.6) | 125 (50.4) | 5 (17.9) | 79 (47.3) | 41 (58.6) | |||
| Older than 45 y | 151 (52.4) | 123 (49.6) | 23 (82.1) | 71 (52.7) | 29 (41.4) | |||
| Age at transplantation | ||||||||
| 6 to 20 y | NA NA | 13 (5.2) | 0 (0.0) | 8 (5.3) | 5 (7.2) | |||
| 21 to 39 y | NA NA | 129 (52.0) | 3 (10.7) | 90 (60.0) | 36 (51.4) | |||
| 40 y or older | NA NA | 106 (42.8) | 25 (89.3) | 52 (34.7) | 29 (41.4) | |||
| Time since transplantation | ||||||||
| 2 to 5 y | NA NA | 92 (37.1) | 19 (67.9) | 42 (28.0) | 31 (44.2) | |||
| 6 y or more | NA NA | 156 (62.9) | 9 (32.1) | 108 (72.0) | 39 (55.7) | |||
| Conditioning regimen | ||||||||
| Chemotherapy | NA NA | 14 (6.1) | 1 (3.6) | 14 (9.3) | 0 (0.0) | |||
| Radiation and chemotherapy | NA NA | 233 (93.9) | 27 (96.4) | 136 (90.7) | 70 (100) | |||
. | Siblings, no. (%) . | Type of transplant . | . | . | . | |||
|---|---|---|---|---|---|---|---|---|
| Characteristics . | . | Any, no. (%) . | Autologous, no. (%) . | Related donor, no. (%) . | Unrelated donor, no. (%) . | |||
| No. | 317 (100.0) | 248 (100.0) | 28 (100.0) | 150 (100.0) | 70 (100.0) | |||
| Sex | ||||||||
| Male | 116 (36.6) | 137 (55.2) | 17 (60.7) | 89 (59.3) | 31 (44.3) | |||
| Female | 201 (63.4) | 111 (44.8) | 11 (39.3) | 61 (40.7) | 39 (55.7) | |||
| Race/ethnicity | ||||||||
| White | 294 (92.7) | 202 (81.4) | 26 (92.9) | 115 (76.7) | 61 (87.1) | |||
| Hispanic | 11 (0.3) | 25 (10.1) | 0 (0.0) | 21 (14.0) | 4 (5.7) | |||
| Other | 12 (0.4) | 21 (8.5) | 2 (7.1) | 14 (9.3) | 5 (7.2) | |||
| Age at interview | ||||||||
| Younger than 45 y | 166 (47.6) | 125 (50.4) | 5 (17.9) | 79 (47.3) | 41 (58.6) | |||
| Older than 45 y | 151 (52.4) | 123 (49.6) | 23 (82.1) | 71 (52.7) | 29 (41.4) | |||
| Age at transplantation | ||||||||
| 6 to 20 y | NA NA | 13 (5.2) | 0 (0.0) | 8 (5.3) | 5 (7.2) | |||
| 21 to 39 y | NA NA | 129 (52.0) | 3 (10.7) | 90 (60.0) | 36 (51.4) | |||
| 40 y or older | NA NA | 106 (42.8) | 25 (89.3) | 52 (34.7) | 29 (41.4) | |||
| Time since transplantation | ||||||||
| 2 to 5 y | NA NA | 92 (37.1) | 19 (67.9) | 42 (28.0) | 31 (44.2) | |||
| 6 y or more | NA NA | 156 (62.9) | 9 (32.1) | 108 (72.0) | 39 (55.7) | |||
| Conditioning regimen | ||||||||
| Chemotherapy | NA NA | 14 (6.1) | 1 (3.6) | 14 (9.3) | 0 (0.0) | |||
| Radiation and chemotherapy | NA NA | 233 (93.9) | 27 (96.4) | 136 (90.7) | 70 (100) | |||
NA indicates not applicable.